Status:
RECRUITING
Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Lung Cancer (NSCLC)
Geriatric Assessment
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
National guidelines recommend that older adults with cancer undergo a special health assessment before starting cancer treatment. This type of assessment evaluates physical function, nutrition, social...
Detailed Description
Comprehensive geriatric assessment (CGA) is one proven mechanism for delineating baseline care needs and improving outcomes in older adults with lung cancer. This type of geriatrician-led assessment, ...
Eligibility Criteria
Inclusion
- Age ≥ 65 years old at time of study enrollment.
- Radiographically or pathologically confirmed stage I-II non-small cell lung cancer.
- All patients must have undergone appropriate complete imaging of their cancer consistent with the standard of care.
- Patient is expected to undergo stereotactic body radiation therapy (SBRT)
- Able to read questions in English or willing to complete survey questionnaires with the assistance of an interpreter.
Exclusion
- There are no exclusion criteria.
Key Trial Info
Start Date :
May 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 26 2026
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06987890
Start Date
May 26 2025
End Date
June 26 2026
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115